Image Protect, Inc. (OTC: IMTL) has recently shared an update on its strategic direction and revenue goals, centering on its InterceptCS™ Cold Sore Prevention System. This product, developed under its subsidiary Global Wellness Products, is a Health Canada-approved Class II Medical Device designed to prevent cold sores, positioning the company in the competitive wellness technology sector.
The global cold sore market, valued at over $3.5 billion annually, offers a lucrative opportunity for Image Protect. The company plans to tap into this demand via a diversified sales approach, including online platforms such as Amazon, Walmart.com, and eBay, with a focus on expanding into the UK, Australia, and the EU markets. With an ambitious revenue target of up to $100 million per year within five years, Image Protect's strategy hinges on the sale of its devices and the recurring purchase of thermal activators by users.
To drive brand recognition and attract customers, Global Wellness Products is deploying an extensive marketing campaign. This initiative includes leveraging social media, paid ads, search engine marketing, and collaborations with influencers. CEO Frank Casella highlighted the distinctive appeal of InterceptCS™, which focuses on prevention rather than treating symptoms, and mentioned ongoing efforts to refine the product for greater consumer appeal and profitability.
Despite the optimistic outlook, Image Protect acknowledges the inherent risks and uncertainties in forward-looking statements, noting that actual outcomes may differ. The company is dedicated to establishing InterceptCS™ as a leading name in personal wellness, supported by regulatory approvals and a strong ecommerce framework.
